1 documents found
Information × Registration Number 0205U002265, 0103U005714 , R & D reports Title Creation and study of the mechanism of action new immune corrector on the basis of a composition of liposome structures from thymic hormones and common its lipids popup.stage_title Head Nykollsky Igor, Доктор медичних наук Registration Date 09-02-2005 Organization Research Centre for Radiation Medicine popup.description2 There are reserved by patents two original schemes of production of the thymic hormone preparations: soluble thymoinductin and its liposome form - thymosomin. The preparations have the high biological activity, that shows the ability for induction of the STLA synthesis. Thymosomin is the immunomodifier wich display in vitro activity in immune reactions - the plasmatic membran receptor expression, the proliferative and cytotoxyc activity of lymphocytes, the absorbtion activity of neutrocytes and TNF-production. Product Description popup.authors popup.nrat_date 2020-04-02 Close
R & D report
Creation and study of the mechanism of action new immune corrector on the basis of a composition of liposome structures from thymic hormones and common its lipids
Head: Nykollsky Igor. Creation and study of the mechanism of action new immune corrector on the basis of a composition of liposome structures from thymic hormones and common its lipids. (popup.stage: ). Research Centre for Radiation Medicine. № 0205U002265
1 documents found

Updated: 2026-03-24


Роздрукувати цю сторінку